We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Partnership to Develop Cardiac PET

By MedImaging staff writers
Posted on 26 Jan 2006
Imagin Molecular Corp. More...
(IMGM, Oakbrook, IL, USA) has entered into an agreement with PET Management Services (PMS, Niagara, NY, USA) to pursue molecular imaging partnerships.

PET Management Services is a developer of molecular imaging systems that bring to IMGM, formerly known as Cipher Multimedia, Inc., the necessary bioinformatics research and imaging center management that validates the usefulness of positron emission tomography (PET) as a primary coronary diagnostic tool.

PMS enables Imagin Nuclear Partners (INP), Imagin Molecular's subsidiary, to provide dedicated evidence-based medical systems for cardiac disease diagnostics and treatments driven by bioinformatics. PMS has data that demonstrate cost-savings to insurance companies when cardiac PET is performed on selected patients as a first-line modality rather than single photon computed tomography (SPECT) scans.

PMS will partner with INP and will operate joint ventures with PET imaging centers. INP is a full-service joint venture molecular imaging partner that will own, operate, and administer out-patient medical diagnostic imaging centers that utilizes PET and PET/CT scanning equipment.

Joe Oliverio, president of PET Management Services stated, "We have one of the most robust cardiac PET patient databases and are preparing to publish manuscripts that will revolutionize the way coronary disease detection and management is performed for decades to come.”




Related Links:
Imagin Molecular

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Digital Radiography System (Ceiling Free)
Digix CF Series
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.